Advertisement

Advertisement

HK:2367 Stock Latest News

Giant Biogene Sets 2026 AGM to Refresh Board Mandates and Appoint New Auditor

Company AnnouncementsGiant Biogene Sets 2026 AGM to Refresh Board Mandates and Appoint New Auditor

Giant Biogene Moves to Replace EY With KPMG as Auditor

PremiumCompany Announcements

Giant Biogene Moves to Replace EY With KPMG as Auditor

21d ago

Giant Biogene Reshapes Corporate Secretariat With New Joint Company Secretary

PremiumCompany Announcements

Giant Biogene Reshapes Corporate Secretariat With New Joint Company Secretary

1M ago

Giant Biogene: Buy Rating on Recovering Growth, High-Value Injectables, and Valuation Support from Buybacks and Channel Expansion

PremiumRatings

Giant Biogene: Buy Rating on Recovering Growth, High-Value Injectables, and Valuation Support from Buybacks and Channel Expansion

2M ago

Giant Biogene Posts Flat Revenue but Lower Profit and Maintains Robust Dividends for 2025

PremiumCompany Announcements

Giant Biogene Posts Flat Revenue but Lower Profit and Maintains Robust Dividends for 2025

2M ago

Giant Biogene Proposes Final Dividend for 2025 Financial Year

PremiumCompany AnnouncementsGiant Biogene Proposes Final Dividend for 2025 Financial Year

2M ago

Giant Biogene Announces Special 2025 Dividend, Signaling Confidence in Cash Position

Company Announcements

Giant Biogene Announces Special 2025 Dividend, Signaling Confidence in Cash Position

2M ago

Giant Biogene Sets March Board Meeting to Approve 2025 Results

Company Announcements

Giant Biogene Sets March Board Meeting to Approve 2025 Results

3M ago

Giant Biogene Wins China Approval for World-First Collagen–Hyaluronate Skin Implant

PremiumCompany Announcements

Giant Biogene Wins China Approval for World-First Collagen–Hyaluronate Skin Implant

4M ago

Giant Biogene Announces Share Repurchase Plan to Enhance Value

PremiumCompany Announcements

Giant Biogene Announces Share Repurchase Plan to Enhance Value

6M ago

Giant Biogene’s Controlling Shareholder Increases Stake to 54.66%

PremiumCompany Announcements

Giant Biogene’s Controlling Shareholder Increases Stake to 54.66%

7M ago

Giant Biogene Gains Approval for Innovative Collagen Product

PremiumCompany Announcements

Giant Biogene Gains Approval for Innovative Collagen Product

7M ago

Giant Biogene’s Controlling Shareholder Increases Stake

PremiumCompany AnnouncementsGiant Biogene’s Controlling Shareholder Increases Stake

7M ago

Giant Biogene’s Controlling Shareholder Increases Stake

Company Announcements

Giant Biogene’s Controlling Shareholder Increases Stake

7M ago

Giant Biogene’s Controlling Shareholder Boosts Stake, Signaling Confidence in Future Growth

Company Announcements

Giant Biogene’s Controlling Shareholder Boosts Stake, Signaling Confidence in Future Growth

8M ago

Giant Biogene’s Controlling Shareholder Increases Stake

PremiumCompany Announcements

Giant Biogene’s Controlling Shareholder Increases Stake

8M ago

Giant Biogene Holding Co. Ltd.: Strong Growth Prospects and Strategic Marketing Drive Buy Rating

PremiumRatings

Giant Biogene Holding Co. Ltd.: Strong Growth Prospects and Strategic Marketing Drive Buy Rating

9M ago

Giant Biogene Reports Strong Interim Financial Results for 2025

PremiumCompany Announcements

Giant Biogene Reports Strong Interim Financial Results for 2025

9M ago

Giant Biogene Announces Formation of Nomination Committee

PremiumCompany Announcements

Giant Biogene Announces Formation of Nomination Committee

9M ago

Giant Biogene Announces Board Composition and Roles

PremiumCompany AnnouncementsGiant Biogene Announces Board Composition and Roles

9M ago

Giant Biogene Announces Upcoming Board Meeting for Interim Results

Company Announcements

Giant Biogene Announces Upcoming Board Meeting for Interim Results

9M ago

Giant Biogene’s Controlling Shareholder Boosts Stake

Company Announcements

Giant Biogene’s Controlling Shareholder Boosts Stake

11M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >